BONESUPPORT HLDG

ISIN SE0009858152

 | 

WKN A2DTSD

Market cap (in EUR)
1,117 m
Country
Sweden
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.
Show more Show less
Healthcare Healthcare Equipment General Medical Devices Sweden

Financials

Key metrics

Market capitalisation, EUR 1,117 m
EPS, EUR 0.21
P/B ratio 14.4
P/E ratio 79.2
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 79 m
Net income, EUR 12 m
Profit margin 14.88%

What ETF is BONESUPPORT HLDG in?

There are 2 ETFs which contain BONESUPPORT HLDG. All of these ETFs are listed in the table below. The ETF with the largest weighting of BONESUPPORT HLDG is the Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing.
ETF Weight Investment focus Fund size (in m EUR)
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing 0.01%
Equity
Europe
Social/Environmental
32
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
494
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.